FDA Inspection 1319186 — Tamatha F. Zemzars, M.D.
The FDA completed an inspection of Tamatha F. Zemzars, M.D. on May 22, 2026 in Saint Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 22, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Petersburg, FL (United States)
Additional details
Clinical BA/BE